Mediterranean diet and time-restricted eating as a cardiac rehabilitation approach for patients with coronary heart disease and pre-diabetes: the DIABEPIC-1 protocol of a feasibility trial.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
17 10 2023
Historique:
medline: 23 10 2023
pubmed: 18 10 2023
entrez: 17 10 2023
Statut: epublish

Résumé

Despite proven programmes, implementing lifestyle interventions for pre-diabetes and type 2 diabetes is challenging. Cardiac rehabilitation, provide a valuable opportunity to promote the adoption of healthy lifestyle behaviours for patients with atherosclerotic cardiovascular disease (ASCVD). However, only a limited number of studies have explored the potential for reversing the underlying causes of ASCVD in this setting. The DIABEPIC1 study is an ongoing single-arm lifestyle clinical trial to assess the feasibility of an upgraded 6-month intensive cardiac rehabilitation programme combining an innovative diet assignment with exercise training to reverse newly onset pre-diabetes (glycated haemoglobin 5.7%-6.4%) to normal glucose concentrations in patients with coronary heart disease. 36 patients referred from the Montreal Heart Institute for cardiac rehabilitation, aged ≥40 years with a recent diagnosis of pre-diabetes in the last 6 months, will be offered to participate in the upgraded programme. Interventions will include four sessions of nutritional counselling on ultra-processed foods intake reduction and a moderate-carbohydrate (<40%) ad libitum Mediterranean diet coupled with 36 1-hour sessions of supervised exercise training (continuous and interval aerobic training, and resistance training) and educational intervention. Phase 2 will continue the same interventions adding 8:16 hour time-restricting eating (TRE) at least 5 days per week. During this second phase, exercise training will be performed with autonomy. The DIABEPIC1 feasibility study is approved by the Research Ethics Board of the Montreal Heart Institute (Project Number ICM 2022-3005). Written informed consent will be obtained from each participant prior to inclusion. Results will be available through research articles and conferences. The DIABEPIC1 trial will examine the feasibility and effectiveness of an enhanced cardiac rehabilitation programme combining exercise training with an ultra-processed food reduction intervention, a Mediterranean diet, and TRE counselling to remit pre-diabetes to normal glucose concentrations. NCT05459987.

Identifiants

pubmed: 37848307
pii: bmjopen-2023-073763
doi: 10.1136/bmjopen-2023-073763
pmc: PMC10582969
doi:

Substances chimiques

Glucose IY9XDZ35W2

Banques de données

ClinicalTrials.gov
['NCT05459987']

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e073763

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Am J Cardiol. 2017 Aug 15;120(4):688-692
pubmed: 28676154
Diabetologia. 2021 Nov;64(11):2359-2366
pubmed: 34458934
Obes Rev. 2009 Jan;10(1):36-50
pubmed: 18700873
Hypertension. 2015 Sep;66(3):698-722
pubmed: 26160955
J Am Heart Assoc. 2021 Feb 2;10(3):e019045
pubmed: 33496188
JAMA. 2018 Feb 20;319(7):667-679
pubmed: 29466592
J Med Internet Res. 2022 Nov 21;24(11):e40449
pubmed: 36409539
Nutr Res Rev. 2016 Dec;29(2):202-233
pubmed: 27821191
Nat Rev Neurol. 2018 Mar;14(3):168-181
pubmed: 29377010
J Am Coll Cardiol. 2021 Aug 3;78(5):453-464
pubmed: 34015477
Eur Heart J. 2019 Aug 7;40(30):2534-2547
pubmed: 31211361
Med Sci Sports Exerc. 2022 Feb 1;54(2):353-368
pubmed: 35029593
Diabetes Res Clin Pract. 2009 Dec;86 Suppl 1:S41-8
pubmed: 20115931
Cell Metab. 2019 Jul 2;30(1):67-77.e3
pubmed: 31105044
Aging Clin Exp Res. 2022 Jul;34(7):1627-1633
pubmed: 35178685
Can J Diabetes. 2022 Dec;46(8):753-761.e8
pubmed: 36567079
Cell Metab. 2020 Jan 7;31(1):92-104.e5
pubmed: 31813824
Eur Heart J. 2021 Mar 21;42(12):1144-1146
pubmed: 33393612
JMIR Mhealth Uhealth. 2020 Sep 9;8(9):e16953
pubmed: 32902389
Nat Commun. 2020 Sep 14;11(1):4592
pubmed: 32929089
PLoS Med. 2020 Oct 28;17(10):e1003396
pubmed: 33112845
Diabetes Res Clin Pract. 2019 Nov;157:107843
pubmed: 31518657
Clin Diabetes Endocrinol. 2019 May 9;5:5
pubmed: 31086677
Diabetes Care. 2022 Jan 1;45(Suppl 1):S17-S38
pubmed: 34964875
Diabetes Care. 2014 Dec;37(12):3188-95
pubmed: 25231895
Diabetes Care. 2018 May;41(5):963-970
pubmed: 29475843
Diabetes Care. 2011 Jan;34(1):14-9
pubmed: 20929998
Nutrients. 2019 Nov 12;11(11):
pubmed: 31726791
Nutrients. 2020 Aug 07;12(8):
pubmed: 32784758
Can J Diabetes. 2022 Dec;46(8):762-774
pubmed: 36567080
BMJ. 2015 Aug 11;351:h3978
pubmed: 26268692
J Intern Med. 2021 Jun;289(6):754-770
pubmed: 33289165
Nutrients. 2019 Jul 18;11(7):
pubmed: 31323831
N Engl J Med. 2018 Oct 04;379(14):1388-1389
pubmed: 30281995
Int J Neurosci. 2021 Nov;131(11):1124-1132
pubmed: 32449872
BMJ. 2018 Feb 14;360:k322
pubmed: 29444771
Lancet Diabetes Endocrinol. 2017 Dec;5(12):935-936
pubmed: 29092776
BMJ. 2000 Aug 12;321(7258):405-12
pubmed: 10938048
Cad Saude Publica. 2010 Nov;26(11):2039-49
pubmed: 21180977
BMC Med. 2020 Aug 13;18(1):235
pubmed: 32787915
Cell Metab. 2020 Sep 1;32(3):366-378.e3
pubmed: 32673591
Arch Neurol. 2011 Jan;68(1):51-7
pubmed: 20837822

Auteurs

Josep Iglesies-Grau (J)

Department of Medicine, Université de Montréal, Montreal, Québec, Canada jiglesies@gmail.com.
Research Center and Centre ÉPIC, Montreal Heart Institute, Montréal, Québec, Canada.

Valérie Dionne (V)

Research Center and Centre ÉPIC, Montreal Heart Institute, Montréal, Québec, Canada.

Élise Latour (É)

Research Center and Centre ÉPIC, Montreal Heart Institute, Montréal, Québec, Canada.

Mathieu Gayda (M)

Research Center and Centre ÉPIC, Montreal Heart Institute, Montréal, Québec, Canada.
Université de Montréal, Montreal, Québec, Canada.

Florent Besnier (F)

Montreal Heart Institute, Montreal, Québec, Canada.

Daniel Gagnon (D)

Research Center and Centre ÉPIC, Montreal Heart Institute, Montréal, Québec, Canada.
Université de Montréal, Montreal, Québec, Canada.

Amélie Debray (A)

Research Center and Centre ÉPIC, Montreal Heart Institute, Montréal, Québec, Canada.

Christine Gagnon (C)

Research Center and Centre ÉPIC, Montreal Heart Institute, Montréal, Québec, Canada.

Véronique Pelletier (V)

Research Center and Centre ÉPIC, Montreal Heart Institute, Montréal, Québec, Canada.

Anil Nigam (A)

Department of Medicine, Université de Montréal, Montreal, Québec, Canada.
Research Center and Centre ÉPIC, Montreal Heart Institute, Montréal, Québec, Canada.

Philippe L L'Allier (PL)

Department of Medicine, Université de Montréal, Montreal, Québec, Canada.
Research Center and Centre ÉPIC, Montreal Heart Institute, Montréal, Québec, Canada.

Martin Juneau (M)

Department of Medicine, Université de Montréal, Montreal, Québec, Canada.
Research Center and Centre ÉPIC, Montreal Heart Institute, Montréal, Québec, Canada.

Nadia Bouabdallaoui (N)

Department of Medicine, Université de Montréal, Montreal, Québec, Canada.
Montreal Heart Institute, Montreal, Québec, Canada.

Louis Bherer (L)

Research Center and Centre ÉPIC, Montreal Heart Institute, Montréal, Québec, Canada.
Université de Montréal, Montreal, Québec, Canada.
Research Center, Institut Universitaire de Gériatrie de Montréal, Montréal, Québec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH